Zobrazeno 1 - 3
of 3
pro vyhledávání: '"Jacques Bagon"'
Autor:
Eduard Apetrei, Hallvard Holdaas, Vincent L.M. Esnault, Edwina A. Brown, Rudolf deChatel, Carlos Calvo, S. Krcmery, Zhanna Kobalava, Jacques Bagon
Publikováno v:
Clinical therapeutics. 30(3)
Placebo-controlled trials have found that angiotensin-converting enzyme inhibitors (ACEIs) decrease proteinuria and slow the progression of nondiabetic nephropathies. However, head-to-head comparisons of ACEIs and calcium channel blockers (CCBs) have
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::6ef62a04c44ba9f01fc84c38ebaaff42
https://pubmed.ncbi.nlm.nih.gov/18405787
https://pubmed.ncbi.nlm.nih.gov/18405787
Autor:
Thierry Pepersack, Jacques Bagon, A. Bergans, G. Mandart, Clémentine Gillet, Michel Fuss, Rafik Karmali, Jacques Corvilain
Publikováno v:
Acta Clinica Belgica. 42:421-430
SummarySarcoidosis was confirmed by biopsy in 13 out of 16 patients in which the disease was suspected. Hypercalcemia was present in 4 patients, associated with renal insufficiency; hypercalciuria without hypercalcemia was found in 3 patients with a
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::7a9c2ced31582a792a475dd36b12b682
https://doi.org/10.1080/22953337.1987.11719260
https://doi.org/10.1080/22953337.1987.11719260
Publikováno v:
Nephron, 20
Parathyroid hormone (PTH), creatinine, calcium and phosphate blood levels were repeatedly measured in 5 patients with acute renal failure. 1 patient developed hypercalcemia during the recovery phase of the illness. PTH was elevated in all cases befor
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::8aa768bdba7a489fca2c7f2d60a219c3
https://doi.org/10.1159/000181222
https://doi.org/10.1159/000181222